Multiple Myeloma - Toxicology

Relevant Publications

Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study.

Issue Release: 2024

Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research.

Issue Release: 2024

Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect.

Issue Release: 2024

Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management.

Issue Release: 2024

Beyond the mouth: Uncovering non-secretory multiple myeloma through oral symptoms.

Issue Release: 2024

Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.

Issue Release: 2024

DNA methylation profiling of labial salivary gland tissues revealed hypomethylation of B-cell-related genes in primary Sjögren\'s syndrome.

Issue Release: 2024

Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m versus 140 mg/m.

Issue Release: 2024

Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features.

Issue Release: 2024

Massive arterial and venous thrombosis from smouldering multiple myeloma: further evidence for monoclonal gammopathy of thrombotic significance.

Issue Release: 2024

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: Results of the multicenter KMMWP2201 study.

Issue Release: 2024

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar.

Issue Release: 2024

Risk of Infection in Patients With Multiple Myeloma Treated With T-Cell Redirecting Approaches: A Call Out for Clinicians.

Issue Release: 2024

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

Issue Release: 2024

Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.

Issue Release: 2024

Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis.

Issue Release: 2024

Personalized Autologous Stem Cell Harvesting Improves Patient Collection Outcomes.

Issue Release: 2024

Interleukin-6 serves as a critical factor in various cancer progression and therapy.

Issue Release: 2024

Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data.

Issue Release: 2024

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma.

Issue Release: 2024

Why is the Incubation Period Important?

How Does Chemical Leaching Occur?

What Defines a Poison?

How Does UPR Relate to Toxicology?

What Are Some Best Practices for Handling Toxic Substances?

How do financial limitations affect toxicological research?

How Are Natural Toxins Studied?

Can Green Tea Cause Toxicity?

Are there implications for educational and training programs?

What Role Does Climate Change Play in Water Pollution?

Multiple Myeloma - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics